Filter the drugs by their status, phase of research and how they help

COVID-19 is respiratory dissease caused by SARS-CoV-2 virus. Browse the database of drugs treating specific mutations compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
N14-R7 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/07/2020 Jul/08/2020 0
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Jul/07/2020 Jul/08/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jul/07/2020 Jul/09/2020 0
Remdesivir Emergency use authorization Experimental Antiviral Jul/07/2020 Jul/09/2020 0
Ritonavir Recommended by guidelines Used to treat other disease Antiviral Jul/07/2020 Jul/09/2020 0
Lopinavir Recommended by guidelines Used to treat other disease Antiviral Jul/07/2020 Jul/09/2020 0
Amlodipine Besylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0
Temsirolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0
Trifluoperazine 2HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0
Vortioxetine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/06/2020 Jul/09/2020 0